Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells
about
Induction of apoptosis and proliferation inhibition of hepatocellular carcinoma by 6-chloro-2-methoxy-N-(phenylmethyl)-9-acridinamine (BA): in vitro and vivo studies.Genetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion.Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells.Lycopene metabolite, apo-10'-lycopenoic acid, inhibits diethylnitrosamine-initiated, high fat diet-promoted hepatic inflammation and tumorigenesis in mice.The critical molecular interconnections in regulating apoptosis and autophagy.Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes.β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling.RPPA-based protein profiling reveals eIF4G overexpression and 4E-BP1 serine 65 phosphorylation as molecular events that correspond with a pro-survival phenotype in chronic lymphocytic leukemia.Rhodium (II) complex with 2-benzoylpyridine, a novel potential chemotherapeutic drug, induces cell cycle arrest and apoptosis in HepG2 cells.Arctigenin, a Natural Lignan Compound, Induces Apoptotic Death of Hepatocellular Carcinoma Cells via Suppression of PI3-K/Akt Signaling.
P2860
Q33868747-87F64CB5-4E82-45C9-96EC-CAC8833AF126Q36144821-5819A36B-C14A-4AFB-9CFA-AFFED6018096Q36414381-594485B2-DB79-461B-ADFC-C28FC3A2E77DQ37590803-73DB0FF0-4672-445A-82B0-6A4A71CB16DBQ38486293-EFD538AB-273B-423E-AE97-1F0B486E1FA0Q38843888-FA10118A-3CBB-43CA-9B9C-B5DBE5CD2858Q38863857-BFEB0D14-DB46-4891-A376-5123AB172DD4Q38872127-60E5A364-8501-4DEE-B341-A2195F7D2C6DQ46290101-2D9BED61-DA0F-46EF-834D-AC5FEB920EF1Q54275107-2ACC9A76-4A56-439B-8C79-BD3332175688
P2860
Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Suppression of AKT anti-apopto ...... hepatocellular carcinoma cells
@ast
Suppression of AKT anti-apopto ...... hepatocellular carcinoma cells
@en
Suppression of AKT anti-apopto ...... hepatocellular carcinoma cells
@nl
type
label
Suppression of AKT anti-apopto ...... hepatocellular carcinoma cells
@ast
Suppression of AKT anti-apopto ...... hepatocellular carcinoma cells
@en
Suppression of AKT anti-apopto ...... hepatocellular carcinoma cells
@nl
prefLabel
Suppression of AKT anti-apopto ...... hepatocellular carcinoma cells
@ast
Suppression of AKT anti-apopto ...... hepatocellular carcinoma cells
@en
Suppression of AKT anti-apopto ...... hepatocellular carcinoma cells
@nl
P2093
P2860
P1433
P1476
Suppression of AKT anti-apopto ...... hepatocellular carcinoma cells
@en
P2093
Andrea Cuconati
Cally Goddard
Courtney Mills
Haitao Guo
Timothy M Block
Xianchao Zhang
Xiaodong Xu
P2860
P304
P356
10.1371/JOURNAL.PONE.0054595
P407
P50
P577
2013-01-01T00:00:00Z